ANTINEOPLASTIC POLYAMINE ANALOGUES
抗肿瘤多胺类似物
基本信息
- 批准号:6514412
- 负责人:
- 金额:$ 24.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-03-01 至 2005-02-28
- 项目状态:已结题
- 来源:
- 关键词:analog antineoplastics athymic mouse breast neoplasms cysteine endopeptidases cytotoxicity drug design /synthesis /production drug screening /evaluation enzyme activity hydrogen peroxide lung neoplasms neoplasm /cancer chemotherapy neoplasm /cancer pharmacology nonhuman therapy evaluation polyamines prostate neoplasms spindle pole body tissue /cell culture tubulin
项目摘要
The polyamine metabolic pathway represents an attractive and novel target for chemotherapeutic intervention in the treatment of neoplastic disease. Interference with the pathway generally leads to a decrease in cellular growth rate, but in some specific instance results in phenotype- specific cytotoxicity. We have developed a number of synthetic routes that provide a pathway to a wide variety of novel unsymmetrically substituted polyamine analogues, many with unique biochemical activities. Forty-three new analogues have been synthesized to date and examined for their anti proliferative activity with the goal of elucidating their mechanism of action. The preliminary results demonstrate major findings provided by the study of these unique analogues. 1) The production of H2O2 produced as a result of analogue induced polyamine catabolism can play a significant role in the phenotype-specific cytotoxic response to some of the most promising analogues; 2) The cytotoxicity produced by the analogues results through caspase-dependent and - independent programmed cell death pathways; 3) A completely novel mechanisms of activity for polyamine analogue have been discovered, specifically the abilities to produced a G2/M block, alter tubulin polymerization and act as spindle poisons; 4) The study of these unique analogues has led to the discovery that the natural polyamines may have the important function of acting as free radical scavengers in protecting chromatin from reactive oxygen species attack. Based on these exciting preliminary results from the major goals of the studies detained in this application are to expand upon the above finding and to perform detailed structure analyses to aid in the production of more effective anti- neoplastic agents.
多胺代谢途径代表了肿瘤疾病治疗中化疗干预的一个有吸引力的新靶点。干扰该途径通常导致细胞生长速率降低,但在某些特定情况下导致表型特异性细胞毒性。我们已经开发了一些合成路线,提供了一个途径,以各种各样的新的不对称取代的多胺类似物,许多具有独特的生物化学活性。迄今为止,已经合成了43种新的类似物,并对其抗增殖活性进行了研究,目的是阐明其作用机制。初步结果表明,这些独特的类似物的研究提供的主要结果。1)多胺类似物诱导的过氧化氢(H_2O_2)的产生在对一些最有希望的类似物的表型特异性细胞毒性反应中起重要作用:2)由类似物产生的细胞毒性通过半胱天冬酶依赖性和非依赖性程序性细胞死亡途径产生; 3)发现了多胺类似物的全新活性机制,特别是产生G2/M阻滞、改变微管蛋白聚合和作为纺锤体毒物的能力; 4)对这些独特的多胺类似物的研究发现,天然多胺可能具有作为自由基清除剂的重要功能,可以保护染色质免受活性氧的攻击。基于这些令人兴奋的初步结果,在本申请中保留的研究的主要目标是扩展上述发现,并进行详细的结构分析,以帮助生产更有效的抗肿瘤剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick M Woster其他文献
Patrick M Woster的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick M Woster', 18)}}的其他基金
Mechanistic probes to study the immune response in periodontal disease
研究牙周病免疫反应的机制探针
- 批准号:
10189556 - 财政年份:2020
- 资助金额:
$ 24.66万 - 项目类别:
Mechanistic probes to study the immune response in periodontal disease
研究牙周病免疫反应的机制探针
- 批准号:
10375549 - 财政年份:2020
- 资助金额:
$ 24.66万 - 项目类别:
Identification of LSD1 inhibitors targeting epigenetic regulation in tumor cells
针对肿瘤细胞表观遗传调控的 LSD1 抑制剂的鉴定
- 批准号:
8215829 - 财政年份:2010
- 资助金额:
$ 24.66万 - 项目类别:
Identification of LSD1 inhibitors targeting epigenetic regulation in tumor cells
针对肿瘤细胞表观遗传调控的 LSD1 抑制剂的鉴定
- 批准号:
8606434 - 财政年份:2010
- 资助金额:
$ 24.66万 - 项目类别:
Identification of LSD1 inhibitors targeting epigenetic regulation in tumor cells
针对肿瘤细胞表观遗传调控的 LSD1 抑制剂的鉴定
- 批准号:
8049747 - 财政年份:2010
- 资助金额:
$ 24.66万 - 项目类别:
Identification of LSD1 inhibitors targeting epigenetic regulation in tumor cells
针对肿瘤细胞表观遗传调控的 LSD1 抑制剂的鉴定
- 批准号:
8444579 - 财政年份:2010
- 资助金额:
$ 24.66万 - 项目类别:
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 24.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 24.66万 - 项目类别:
Engage Grants Program
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6623455 - 财政年份:2002
- 资助金额:
$ 24.66万 - 项目类别:
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6465958 - 财政年份:2002
- 资助金额:
$ 24.66万 - 项目类别:
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 24.66万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 24.66万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 24.66万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 24.66万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 24.66万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 24.66万 - 项目类别: